methadone has been researched along with tamoxifen in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, SH; Chiang, YC; Ho, IK; Ho, WJ; Huang, CL; Lane, HY; Ma, WL; Wang, RY; Yang, HT | 1 |
| Chang, WC; Cheng, WC; Chiang, YC; Ho, IK; Huang, CL; Lane, HY; Ma, WL; Su, YT; Yang, JC | 1 |
2 review(s) available for methadone and tamoxifen
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for methadone and tamoxifen
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine | 2012 |
Reduced dosing and liability in methadone maintenance treatment by targeting oestrogen signal for morphine addiction.
Topics: Adult; Animals; Cytochrome P-450 CYP2B6; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation; Humans; Male; Methadone; Mice; Mice, Inbred C57BL; Morphine Dependence; Opiate Substitution Treatment; Ovariectomy; Polymorphism, Single Nucleotide; Pyrrolidines; Response Elements; Sex Factors; Signal Transduction; Tamoxifen | 2017 |
Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment.
Topics: Adult; Aged; Analgesics, Opioid; Animals; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Heroin Dependence; Humans; Male; Methadone; Mice, Knockout; Middle Aged; Opiate Alkaloids; Opiate Substitution Treatment; Opioid-Related Disorders; Polymorphism, Single Nucleotide; Selective Estrogen Receptor Modulators; Sex Factors; Signal Transduction; Taiwan; Tamoxifen; Young Adult | 2021 |